Use of Monoclonal Antibodies Against Autoimmune Diseases By: Kelly Sambuchi ISAT 351 Spring 1999.

Slides:



Advertisements
Similar presentations
Antibody Production.
Advertisements

Dr.Mohammed Sharique Ahmed Quadri Assistant professor Physiology
Applications of Biotechnological Processes Antibody Production.
Introduction by Period 6, 2014
Topic Defence against infectious disease
Chapter 43 Notes The Body’s Defenses. Nonspecific Defenses Against Infection The skin and mucous membranes provide first-line barriers to infection -skin.
Connect! Did you get a swine flu vaccination? What is a vaccination?
Diagnostic Immunology Topic: Immunological Tolerance Objectives: Define Immunological tolerance Define Immunological tolerance Discuss mechanism of tolerance.
Understanding the Immune System
Immunity Chapter 40 Section 2. Lymphatic System.
Immune System.
The Immune System. First lines of defense: Skin Mucus Stomach acid Digestive enzymes.
Immune System Chapter 14.
The Immune System Specific Immunity. What You Should Know Immune surveillance A range of white blood cells constantly circulate monitoring the tissues.
The Immune System The body’s line of defense against disease happens here.
{ Chapter 47 The Immune system.  What is a pathogen?  Any agent that causes disease  Koch was the first to establish how to identify individual pathogens.
MONOCLONAL ANTIBODIES SEMINAR PRESENTATION Performed by PASCHALIS KOURELIAS MSc BIOMEDICAL IMMUNOLOGY EAST LONDON UNIVERSITY STRATFORD 09 /12/2003.
Immunity : The Immune system plays a role in combating infection, creating inflammation (& consequently heart disease), controlling (or not) cancer and.
Immunity 6.5 Antibodies.
Topic 11: Human Health and Physiology 11.1 Defense Against Infectious Diseases.
The Immune System. Immune System Our immune system is made up of: The innate immune system: first line of defence (non-specific) The adaptive immune system:
Specific immune system
2 pt 3 pt 4 pt 5pt 1 pt 2 pt 3 pt 4 pt 5 pt 1 pt 2pt 3 pt 4pt 5 pt 1pt 2pt 3 pt 4 pt 5 pt 1 pt 2 pt 3 pt 4pt 5 pt 1pt Structures Disease & Disorder ImmunitySystems.
MONOCLONAL ANTIBODIES
Lec 16 Medical biotechnology Shah Rukh Abbas, PhD
Daniel Burukhin, Kyle Yoshihara, Jack Curtis, Graham Wrightson, Jacob Jorgensen.
Lymphatic (Immune) System Nestor T. Hilvano, M.D., M.P.H. (Images Copyright Discover Biology, 5 th ed., Singh-Cundy and Cain, Textbook, 2012.)
Lymphatic System Questions 1. Transports excess fluid away from tissues and return it to the bloodstream. Also help defend the body against infections.
Monoclonal Antibodies Aims: Must be able to define the term monoclonal antibody. Should be able to outline the possible uses of monoclonal antibodies.
How do your body systems protect you from infection and disease?
Third Line of Defence Aims: Must be able to state the substances involved in the third line of immunity. Should be able to describe the production and.
Specific Immune System
BCM 410A lecture 35 immunity immunoglobulin structure antibody classes monoclonal antibodies immunity immunoglobulin structure antibody classes monoclonal.
Lecture 23 Immune System. Introduction A human or animal must defend itself against multitude of different pathogens including viruses, bacteria, fungi,
APPLICATIONS OF MONOCLONAL ANTIBODIES
Chapter 16 Immunological Tolerance. Contents Part Ⅰ Introduction Part Ⅱ Mechanisms of Self Tolerance Part Ⅲ Factors affecting Induced Tolerance Part Ⅳ.
Specific Defenses of the Host
IMMUNE SYSTEM OVERVIEW
Basic Immunology The Immune system must have the ability to distinguish between self and non-self molecules Self Molecules- components of an organism’s.
AUTOIMMUNITY. Self/Non-self Discrimination Autoimmunity is a problem of self/non-self discrimination.
Protection Against Disease Antibody Mediated Immunity- B cells.
TYPE III & IV HYPERSENSITIVITY REACTION 1 Hypersensitivity reaction.
 Involves specificity & memory, increases effectiveness with each exposure to an antigen  Antigens: Substances that stiumulate adaptive immunity responses.
Immunology B cells and Antibodies – humoral
Chapter 15 Care of the Patient with an Immune Disorder Mosby, Inc. items and derived items copyright © 2003, 1999, 1995, 1991 Mosby, Inc.
Part 1. Learning Intentions Define the immune system Identify different components of the immune system Identify components of the lymphatic system.
The Immune System. Protects our bodies from pathogens – disease causing agents May be bacteria, viruses, protists, fungi, etc Response could be nonspecific.
Daily Warm-up March 19th During the Quarter Quell, Katniss Everdeen searches for water in the arena. Before she found it, she began to become dehydrated.
Antibody Production.
The Immune System The Immune System
Immune System Chapter 43 AP/IB Biology.
Immune system April 2016.
CHAPTER 24 The Immune System
The Body’s Defense Against Pathogens -- Memory
Unit 4 - Immunology and Public Health
Immunology & Public Health
Chapter 43 Notes The Body’s Defenses.
Immune System Chapter 14.
Immune System.
Immunology & Public Health
Immune System Chapter 14.
Autoimmune Diseases Occasionally the immune system loses the ability to recognize the body’s own cells. The immune system then begins destroying the body’s.
Chapter 21: Immune System
What is your immune System like? Write a sentence for each metaphor .... starter.
Immunology Dr. Refif S. Al-Shawk
Specific Cellular Defences Against Pathogens
Lec 6 Monoclonal Antibody.
The Lymphatic System and Immunity
Presentation transcript:

Use of Monoclonal Antibodies Against Autoimmune Diseases By: Kelly Sambuchi ISAT 351 Spring 1999

Outline n Terminology n Introduction n What is Autoimmune Disease? n Use of Monoclonal Antibodies n Case Studies n Summary n Conclusion

Terminology n Hybrids: The fusion of two cell membranes and two dissimilar nuclei n Monoclonal Antibodies: Developed as a hybrid, cell that will bind to a specific site and produce antibodies in larger quantities n Immune System: System that defends against foreign agents that infect the body

Terminology (cont.) n Autoimmune Disease: Result of a malfunctioning immune system that has in effect “lost control” of its necessary responses.

Introduction n Why monoclonal antibodies? n For many years scientists had been creating cell hybrids for scientific research. These cell hybrids were functional for research purposes, maintaining some properties of each parent cell, however they would loose some chromosomes in production. n In 1975 two scientists Kohler and Milstein discovered monoclonal antibodies

The Discovery n Kohler and Milstein attempted to fuse together antibody producing mouse spleen cells with mouse myeloma cells n They discovered with this fusion they had created a cell which “secreted antibodies of the specificity dictated by the parent spleen cell, but in the quantity characteristic of a myeloma cell (Hurrell)”

Autoimmune Disease n In a normal immune system two cells play vital roles in the response to invading agents n The first cell is the B lymphocyte cell n The second cell is the T lymphocyte cell

The B Lymphocyte Cell In A Normal Immune System n When a foreign substance is identified in the body B cells produce antibodies which will attack the foreign molecule forming antigen aggregates n Both the antibodies and antigen aggregates are taken in by the phagocytic cells and fused with lysosomes to be digested

The B Lymphocyte Cell In A Malfunctioning Immune System n The B cell will produce autoantibodies, which react with the individuals own tissue rather than the foreign substance n These autoantibodies will deposit within the tissue, which in turn produces an inflammatory response in the tissue resulting in tissue damage

The T Lymphocyte Cell In A Normal Immune System n Similar to B cells, T cells are activated by the presence of a foreign substance n A foreign substance is recognized by the receptor found on the surface of the T cells n T cells undergo thymic education, where they are programmed to activate when they encounter a particular foreign substance

T Lymphocyte Cells In A Malfunctioning Immune System n Thymic education can be thought of as a screening processes, T cells that exit the thymus have been properly programmed and can be thought of as “good” T cells n Occasionally “bad” T cells exit the thymus n These T cells have a high affinity for self molecules

T Lymphocyte Cells In A Malfunctioning Immune System n T cells with a high affinity to self molecules will react with an individuals own tissue –Expressing a CD4 Receptor targeted to Major Histocompatibility Complex II n When “bad” T cells are activated they signal the B cell to produce the autoantibodies which in turn attack healthy tissue, resulting in autoimmune disease

A Second Method To The Development of a Malfunctioning Immune System n In the event that no “bad” T cells exit the thymus, autoimmune disease can still occur n This occurs when T cells in a tolerant state become activated by the stimulus of a large infection, such as a life threatening illness n If T cells do not return to a tolerant state after the infection clears, they will still be targeted to the now healthy tissue

The Use of Monoclonal Antibodies Against Autoimmune Diseases n A monoclonal antibody is produced through the fusion of a B cell with an antigen and a cell with a B cell tumor n Thus, creating a “missile” cell that will hone in on a specific “target” n What does this mean for Autoimmunity?

The Use of Monoclonal Antibodies Against Autoimmune Diseases n If a monoclonal antibody where to be “targeted” to bind to the CD4 receptor of “bad” T cells it could bind to the receptor blocking it n By blocking the receptor the monoclonal antibody has prevented the receptor from further binding to the MHC-II site, preventing activation n Without activation it would be unable to clone itself, and would enter a state of tolerance

Case Studies n Throughout the last several decades many treatments have been attempted to alleviate the symptoms of Autoimmune Disease with little success –Corticosteroid Drugs –Ionizing Radiation –Surgical Excision

Case Study 1 n Rheumatoid Arthritis –Double-blind, Placebo Clinical Trial n Patients Received –Placebo or Chimeric Monoclonal Antibody known as cA2 n Dosages –5, 10 or 20 mg/kg n Analysis –NOS 2 Protein and NOS Enzyme Activity

Results of Case Study 1 n The analysis concluded that there were significant changes in the NOS activity of patients who received the chimeric monoclonal antibody, resulting in decreased joint tenderness, a common effect of Rheumatoid Arthritis

Case Study 2 n Rheumatoid Arthritis –Double-blind, Placebo random selection n Patients Received –Non-depleting Monoclonal Antibody (Mab) –Placebo n Dosages –450 mg (Mab) n Analysis –Production of mitogen-stimulated peripheral blood T cells

Results of Case Study 2 n The results clearly showed an immediate decrease in CD4 reactive protein levels by those individuals who originally received the anti-CD4 Mab, as well as clinical benefits.

Summary n The continued efforts of scientists and research laboratories around the world, as well as the funding of nonprofit organization such as the AARDA will hopefully eventually determine a cure as well as improved diagnostics against Autoimmunity. The monoclonal antibody is a new concept in the world of science, having been discovered in The increased awareness of the monoclonal antibodies and its numerous possible applications will only continue in this field of biotechnology.

In Conclusion n The studies performed using monoclonal antibodies against Autoimmune Disease have shown remarkable results. In the various case studies presented in this paper all showed improvement in the patients receiving the various treatments and little to no change in the placebo groups. Studies such as these, which prove the increased possibilities of monoclonal antibodies, can only help to further study this area of science. It is only when studies prove effective that research continues, thus the field of biotechnology exploring monoclonal antibodies and their uses continues.

THE END